Overview

Open-Label Extension of Other SZ1839 (Iressa) Trials

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
A trial to assess patients who have been treated with Iressa in a previous clinical trial and may benefit from continued treatment with Iressa.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Gefitinib